Status:
RECRUITING
Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
Lead Sponsor:
IRCCS SYNLAB SDN
Collaborating Sponsors:
University Federico II of Naples, Department of Clinical and Surgical Medicine
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Thyroid cancer (TC) is the most common endocrine malignancy, with well-differentiated thyroid carcinomas (DTCs)-papillary (PTC) and follicular (FTC)-comprising the majority of cases. While DTCs genera...
Eligibility Criteria
Inclusion
- Patients of either sex aged \> 18 years with thyroid cancer of follicular origin.
Exclusion
- Patients who do not fit the inclusion criteria.
Key Trial Info
Start Date :
March 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06878534
Start Date
March 13 2023
End Date
March 31 2027
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs Synlab Sdn
Naples, Italy, 80146